Salt Lake City, UT, March 25, 2026 (GLOBE NEWSWIRE)-- Recursion (Nasdaq: RXRX), a leading clinical-stage TechBio company decoding biology to radically improve lives, today announced that Vicki Goodman ...

Abstract: In the automation era, DC motors are widely utilized across various industries due to their adaptability and efficiency. In the downside of reality, accurately modelling and controlling ...

Abstract: The development of polarization-adjusted convolutional (PAC) codes has introduced a class of efficient designs for short packet transmission. In this contribution, aiming at more flexible ...

Forbes contributors publish independent expert analyses and insights. John Sviokla covers GenAI/AI's impact on commerce and society. This voice experience is generated by AI. Learn more. This voice ...

Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) is one of the stocks Jim Cramer answered questions about. When a caller mentioned that Cathie Wood invested in the stock, Cramer remarked, “That’s, it’s a ...